Диссертация (1154655), страница 24
Текст из файла (страница 24)
Massenkeil, F. Er // World J Gastroenterol. – 2014. – vol.20(42). – p. 15492-8. - doi: 10.3748/wjg.v20.i42.15492.101. Gheorghiade, M. Acute Heart Failure Syndromes / M. Gheorghiade, P.S. Pang // JAm Coll Cardiol. – 2009. –vol.53. – p.557 – 573.102. Giallourakis, C.C. Liver complications in patients with congestive heart failure.Gastroenterol Hepatol. (NY). – 2013. – vol.9(4). –p. 244-246.103. Gitlin, N. Ischemic hepatitis: widening horizons / N.
Gitlin, K.M. Serio // Am JGastroenterol. – 1992. – vol. 87. – p.831–836.104. Golab, F. Ischemic and non-ischemic acute kidney injury cause hepatic damage / F.Golab, M.Kadkhodaee, M. Zahmatkesh, M. Hedayati, H. Arab, R.Schuster, K. Zahedi,A. Lentsch and M. Soleimani // Kidney International. – 2009.
– vol. 75(8). – p. 783-792.doi: 10.1038/ki.2008.683.105. Gordon Jiang, Z. Aspirin use is associated with lower indices of liver fibrosis amongadults in the United States / Z. Gordon Jiang, L. Feldbrügge, E. B. Tapper, Y. Popov, T.Ghaziani, N. Afdhal, S.C. Robson and K.J. Mukamal // Alimentary Pharmacology &Therapeutics. – 2016. – vol.
43(6). – p. 734-743.106. Granger, C.B. Apixaban versus warfarin in patients with atrial fibrillation / C.B.Granger, J.H. Alexander, J.J. McMurray, et al. // N Engl J Med. – 2011. – vol. 365. – p.981–992.132107. Greenberg, B. Novel Therapies for Heart Failure – Where Do They Stand? Circ J. –2016. – vol.80. – p.1882–1891.108. Heidenreich, P.A. Forecasting the Impact of Heart Failure in the United States: APolicy Statement From the American Heart Association / P.A. Heidenreich, et al.
// CircHeart Fail. – 2013. – vol. 6(3). – p. 606–619.109. Henrion, J. Hypoxic hepatitis in patients with cardiac failure: incidence in a coronarycare unit and measurement of hepatic blood flow / J. Henrion, O. Descamps, R. Luwaert,M. Schapira, A.Parfonry, F.Heller // J Hepatol.
-1994. – vol.21. –p.696–703. http://dx.doi.org/10.1016/s0168-8278(94)80226-2.110. Henrion, J. Hypoxic hepatitis: clinical and hemodynamic study in 142 consecutivecases / J. Henrion, M. Schapira, R. Luwaert, L. Colin, A. Delannoy, F.R. Heller //Medicine (Baltimore). – 2003. – vol. 82(6). – p. 392-406.111.
Henrion, J. Hypoxic hepatitis. Liver Int. – 2012. – vol.32. –p.1039–1052.112. Henrion, J. Hypoxic hepatitis: clinical and hemodynamic study in 142 consecutivecases / J.Henrion, M. Schapira, R. Luwaert, L. Colin, A. Delannoy, F.R. Heller //Medicine (Baltimore). – 2003. –vol. 82. – p. 392–406.113. Hepner, G.W. Reduced drug elimination in congestive heart failure. Studies usingaminopyrine as a model drug / G.W.
Hepner, E.S .Vesell, K.R. Tantum // Am J Med. –1978. –vol.65. –p.371–376.114. Herzer, K. Onset of heart failure determines the hepatic cell death pattern. / HerzerK., Kneiseler G., Bechmann L.P., et al. // Ann Hepatol. - 2011. - vol.10. – p. 174 - 179.115. Hopper, I. Impact of heart failure and changes to volume status on liver stiffness:non- invasive assessment using transient elastography / I. Hopper, W. Kemp, P.Porapakkham, Y.
Sata, E.Condon, M. Skiba, L. Farber, T.J. Williams, S. Menahem, S.Roberts, H. Krum // Eur J Heart Fail. – 2012. –vol.14. – p.621-627.116. Houston, B.A. Volume Overload in Heart Failure: An Evidence-Based Review ofStrategies for Treatment and Prevention / B.A. Houston, R.J. Kalathiya, D.A. Kim and S.Zakaria // Mayo Clin Proc.
– 2015. – vol. 90(9). – p. 1247-1261.117. Jager, B. Jaundice increases the rate of complications and one-year mortality inpatients with hypoxic hepatitis / B. Jager, A.Drolz, B. Michl, et al. // Hepatology. – 2012.133– vol. 56. – p. 2297-2304.118. John, R. Acute Decompensated Heart Failure / R. John, J.R. Teerlink, K. Alburikan,M. Metra and Jo E. Rodgers // Update Current Cardiology Reviews.
– 2015. – vol.11. –p. 53-62.119. Kamath, P.S. A model to predict survival in patients with end-stage liver disease /P.S. Kamath, R.H. Wiesner, M. Malinchoc, W. Kremers, T.M. Therneau, С.L. Kosberg,G. D’Amico, E.R. Dickson, W.R. Kim // Hepatology. – 2001. – vol. 33. – p.464–470.120. Kato, T.S. Pre-operative and post-operative risk factors associated with neurologiccomplications in patients with advanced heart failure supported by a left ventricular assistdevice / T.S.
Kato, P.C. Schulze, J. Yang J, et al. // J Heart Lung Transplant. – 2012. –vol.31. – p.1–8.121. Kavoliuniene, A. Congestive hepatopathy and hypoxic hepatitis in heart failure: Acardiologist's point of view / A. Kavoliuniene, A. Vaitiekiene, G. Cesnaite // InternationalJournal of Cardiology. – 2013. – vol. 166. – p. 554–558.122. Kawase, Y.
Abundant apoptosis in nutmeg liver of cardiomyopathic hamsters.Apoptotic cell death as a possible mechanism of hepatic remodeling by congestion / Y.Kawase, G. Takemura, K. Hayakawa, M. Koda, R. Maruyama, M. Kanoh, A. Kunishima,M. Arai, S. Minatoguchi, T. Ohkusa, M. Matsuzaki, T.
Fujiwara, H. Fujiwara // PatholRes Pract. - 2002. – vol. 198(4). – p. 291-298.123. Kim, M.S. Hepatic dysfunction in ambulatory patients with heart failure: applicationof the MELD scoring system for outcome prediction / M.S. Kim, T.S. Kato, M. Farr, C.Wu, R.C. Givens, E.Collado, et al. // Journal of the American College of Cardiology. –2013. – vol.61(22). – p.2253-2261.124. Kinugasa, Y. A simple risk score to predict in-hospital death of elderly patients withacute decompensated heart failuredhypoalbuminemia as an additionalprognostic factor / Y. Kinugasa, M.
Kato, S. Sugihara, et al. // Circ J. – 2009. – vol.73. –p.2276–81.125. Kisloff, B. Fulminant hepatic failure secondary to congestive heart failure / B.Kisloff, G. Schaffer // Am J Dig Dis. – 1976. – vol.21. –p. 895-900.126. Kosanam, S. Drug –induced liver injury: A review / Sreya Kosanam, Revathi Boyina134// International Journal of Pharmacological Research. – 2015. – vol.5(2). – p. 24-30.127.
Kostis, J.B. Differences among ACE inhibitors. Am J Hypertens. - 2010. – vol.23.– p.1156. doi: 10.1038/ajh.2010.170.128. Kuriakose A. Immunogenicity of Biotherapeutics: Causes and Association withPosttranslational Modifications // A. Kuriakose A., N. Chormule, P. Nair. J Immunol Res.2016; 2016: 1298473.
Published online 2016 Jun 29. doi: 10.1155/2016/1298473129. Lainscak, M. Pharmacokinetics and pharmacodynamics of cardiovascular drugs inchronic heart failure / M. Lainscak, C. Vitale, P. Seferovic, I. Spoletini, K. Cvan Trobec,G.M. Rosano // Int J Cardiol. – 2016. – vol. 224. – p. 191- 198.130. Lane, K., Dixon, J., MacPhee, I. and Philips, B. (2013).
Renohepatic crosstalk: doesacute kidney injury cause liver dysfunction?. Nephrology Dialysis Transplantation. – vol.28 (7). - p. 1634 - 1647.131. Laribi, S. Cardiohepatic Syndrome: Liver Injury in Decompensated Heart Failure /S. Laribi, A. Mebazaa // Curr Heart Fail Rep. – 2014. – vol.11(3). – p.236-240.132. Lau, G.T. Type of liver dysfunction in heart failure and its relation to the severity oftricuspid regurgitation / G.T. Lau, H.C. Tan, L.
Kritharides // Am J Cardiol. – 2002. –vol.90. – p.1405 – 1409.133. Lebray, P. Liver stiffness is an unreliable marker of liver fibrosis in patients withcardiac insufficiency / P. Lebray, S. Varnous, F. Charlotte, A. Varaut, T. Poynard, V.Ratziu // Hepatology. – 2008. – vol.48(6). – p.2089.134. Lietz, K. Outcomes of left ventricular assist device implantation as destinationtherapy in the post-REMATCH era: implications for patient selection / K.
Lietz, J.W.Long, A.G. Kfoury, et al. // Circulation. – 2007. – vol.116. – p. 497–505.135. Lindvig, K. Liver stiffness and 30-day mortality in a cohort of patients admitted tohospital / K.Lindvig, B.K. Mössner, C. Pedersen, S.T.Lillevang, P.B. Christensen // EurJ Clin Invest. – 2012. – vol. 42. – p.146 – 152.136. Malinchoc, M. A model to predict poor survival in patients undergoing transjugularintrahepatic portosystemic shunts / M.
Malinchoc, P.S. Kamath, F.D. Gordon, C.J. Peine,J. Rank, P.C. ter Borg // Hepatology. – 2000. – vol. 31. – p. 864–871.137. Martinez, S.M. Noninvasive assessment of liver fibrosis / S.M. Martinez, G. Crespo,135M.Navasa, X. Forns // Hepatology. – 2011. – vol.53. – p.325 – 335.138. Masoumi, A.
Mineralocorticoid receptor antagonists as diuretics: Can congestiveheart failure learn from liverfailure? / A. Masoumi, F. Ortiz, J. Radhakrishnan, R.W.Schrier, P.C. Colombo // Heart Fail Rev. – 2015. – vol. 20(3). – p.283-290. doi:10.1007/s10741-014-9467-2.139. Mebazaa, A. Recommendations on pre-hospital and early hospital management ofacute heart failure: a consensus paper from the Heart Failure Association of the EuropeanSociety of Cardiology, the European Society of Emergency Medicine and the Society ofAcademic Emergency Medicine – short version / A.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
